Loading company…
Vaxxas Pty Ltd develops and commercializes Nanopatch, a needle-free vaccine delivery system based in Sydney, Australia.
Founded in 2011 and based in Sydney, Australia, Vaxxas Pty Ltd develops and commercializes a needle-free vaccine delivery system called the Nanopatch. In August 2025 it raised USD 49 million in Series D funding from new investor LGT Crestone Wealth Management, with returning investors Brandon Capital Partners and OneVentures participating. The round was part of a larger USD 89 million Series D and venture debt funding, and the company plans to use the money to expand production of its needle-free vaccine patches and support clinical trials. It is at the Series D stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in